OncoInsight Co., Ltd.
- Biotech or pharma, therapeutic R&D
OncoInsight is at the forefront of developing breakthrough medicines to address the unmet needs of patients with refractory and challenging medical conditions, including solid tumors and autoimmune diseases, through innovative NK immune cell therapy.
OncoInsight has demonstrated exceptional anti-tumor performance of its NK cells through both in vitro studies with various solid tumor cell lines and in vivo experiments using mouse cancer models. OncoInsight is also developing a novel B cell-targeting cell therapy for the treatment of B cell-related autoimmune diseases, with a specific focus on Systemic Lupus Erythematosus (SLE).
We are actively seeking collaboration opportunities with antibody development companies that possess proprietary antibodies and are interested in co-developing combination therapies or CAR-NK cell therapy.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}